Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors

被引：1

作者：

Meguro, Masaki ^{[1
]}

Miyauchi, Satoru ^{[2
]}

Kanao-Arisumi, Yukiko ^{[3
]}

Naito, Satoru ^{[4
]}

Suzuki, Kanae ^{[1
]}

Inoue, Shinichi ^{[5
]}

Yamada, Keisuke ^{[6
]}

Homma, Tsuyoshi ^{[1
]}

Chiba, Kiyoshi ^{[1
]}

Nara, Futoshi ^{[7
]}

Furuzono, Shinji ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Technol Div, Technol Business Management Grp, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan

[3] Pharmaun Co Ltd, 1-23-39 Hiikawa,Jounan Ku, Fukuoka, Fukuoka 8140153, Japan

[4] Daiichi Sankyo Business Associe Co Ltd, Site Operat Dept, Shinagawa Site Operat Grp, 1-2-58 Hiromachi,Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA

[6] Daiichi Sankyo Co Ltd, Med Affairs Div, Med Affairs Planning Dept, 3-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038426, Japan

[7] Shin Nippon Biomed Labs Ltd, 8-1-28 Akashicho,Chuo Ku, Tokyo 1040044, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 108卷

关键词：

Aldosterone; Aldosterone synthase inhibitor; Sulfone; Amino-pyrimidine; IN-VIVO ACTIVITY; POTENTIAL TREATMENTS; DISCOVERY; LCI699; THIOLS;

D O I：

10.1016/j.bmc.2024.117775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile 2 was identified as a novel potent aldosterone synthase inhibitor. Compound 2 was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound 2 showed more than 80 times higher selectivity over human CYP11B1 in vitro.

引用

页数：15

共 50 条

[41] Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors
Liu, Yongfu
Wu, Jun
Zhou, Mingwei
Chen, Wenming
Li, Dongbo
Wang, Zhanguo
Hornsperger, Benoit .
Aebi, Johannes D.
Marki, Hans-Peter
Kuhn, Bernd
Wang, Lisha
Kuglstatter, Andreas
Benz, Jorg
Muller, Stephan
Hochstrasser, Remo
Ottaviani, Giorgio
Xin, Jian
Kirchner, Stephan
Mohr, Susanne
Verry, Philippe
Riboulet, William
Shen, Hong C.
Mayweg, Alexander V.
Amrein, Kurt
Tan, Xuefei
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (13) : 6876 - 6897
[42] Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene
Wasniewska, M
De Luca, F
Valenzise, M
Lombardo, F
De Luca, F
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (01) : 59 - 62
[43] Variation at the aldosterone synthase gene locus (CYP11B2) is associated with human essential hypertension
Davies, E
Anderson, N
Jamieson, A
Inglis, G
Fraser, R
Friel, E
Holloway, C
Morrison, C
Connell, JMC
JOURNAL OF HYPERTENSION, 1998, 16 : S51 - S51
[44] Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3
Taymans, SE
Pack, S
Pak, E
Torpy, DJ
Zhuang, ZP
Stratakis, CA
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03): : 1033 - 1036
[45] Aldosterone synthase (CYP11B2)-344 C/T polymorphism is related to antihypertensive response
Kurland, L
Melhus, H
Karlsson, J
Kahan, T
Malmqvist, K
Öhman, P
Nyström, F
Hägg, A
Lind, L
AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (05) : 389 - 393
[46] Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review
Miao, Hui
Yu, Zhongxun
Lu, Lin
Zhu, Huijuan
Auchus, Richard J.
Li, Jiayan
Jiang, Jun
Pan, Hui
Gong, Fengying
Chen, Shi
Lu, Zhaolin
STEROIDS, 2019, 150
[47] Discovery of selective CYP11B2 inhibitors as potential treatments for resistant hypertension
Hoyt, Scott
Petrilli, Whitney
Park, Min
Taylor, Jerry
London, Clare
Cooke, Andrew
Cai, Jiaqiang
Carswell, Emma
Robinson, John
Maclean, John
Brown, Lindsay
Belshaw, Simone
Clarkson, Tom
Bennett, David
Liu, Kun
Liang, Gui-Bai
Ujjainwalla, Feroze
Tata, Jim
Hu, Qingzhong
Yin, Lina
van Koppen, Chris
Hartmann, Rolf
Kulkarni, Bheemashankar
Samanta, Swapan
Saxena, Rohit
Struthers, Mary
Cully, Doris
Wisniewski, Tom
Ren, Ning
Bopp, Charlene
Sok, Andrea
Cai, Tian-Quan
Stribling, Sloan
Pai, Lee-Yuh
Ma, Xiuying
Metzger, Joseph
Verras, Andreas
McMasters, Daniel
Chen, Qing
Tung, Elaine
Tang, Wei
Salituro, Gino
Buist, Nicole
Clemas, Joe
Zhou, Gaochao
Rosenbach, Mark
Xiong, Yusheng
Ali, Amjad
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[48] Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma
Yoshii, Yoko
Oki, Kenji
Gomez-Sanchez, Celso E.
Ohno, Haruya
Itcho, Kiyotaka
Kobuke, Kazuhiro
Yoneda, Masayasu
HYPERTENSION, 2016, 68 (06) : 1432 - 1437
[49] Selective Suppression of Aldosterone Production in Non-Human Primates by SE-6440, a Potent and Highly-Selective Inhibitor of Aldosterone Synthase (CYP11B2)
Becherer, J. David
Garvey, Edward P.
Hoekstra, William J.
Schotzinger, Robert J.
Sparks, Steven M.
CIRCULATION, 2018, 138
[50] Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio
Lim, PO
MacDonald, TM
Holloway, C
Friel, E
Anderson, NH
Dow, E
Jung, RT
Davies, E
Fraser, R
Connell, JMC
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09): : 4398 - 4402

← 1 2 3 4 5 →